Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus
Publication date
2001-08-11
Authors
Boer, R.J. de
Oprea, M. (Mihaela)
Antia, R. (Rustom)
Murali-Krishna, K. (Kaja)
Ahmed, R. (Rafi)
Perelson, A.S. (Alan)
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
The specific CD8+ T-cell response during acute lymphocytic choriomeningitis virus (LCMV) infection of
mice is characterized by a rapid proliferation phase, followed by a rapid death phase and long-term memory.
In BALB/c mice the immunodominant and subdominant CD8+ responses are directed against the NP118 and
GP283 epitopes. These responses differ mainly in the magnitude of the epitope-specific CD8+ T-cell expansion.
Using mathematical models together with a nonlinear parameter estimation procedure, we estimate the
parameters describing the rates of change during the three phases and thereby establish the differences
between the responses to the two epitopes. We find that CD8+ cell proliferation begins 1 to 2 days after
infection and occurs at an average rate of 3 day^(-1), reaching the maximum population size between days 5 and
6 after immunization. The 10-fold difference in expansion to the NP118 and GP283 epitopes can be accounted
for in our model by a 3.5-fold difference in the antigen concentration of these epitopes at which T-cell
stimulation is half-maximal. As a consequence of this 3.5-fold difference in the epitope concentration needed
for T-cell stimulation, the rates of activation and proliferation of T cells specific for the two epitopes differ
during the response and in combination can account for the large difference in the magnitude of the response.
After the peak, during the death phase, the population declines at a rate of 0.5 day^(-1), i.e., cells have an average
life time of 2 days. The model accounts for a memory cell population of 5% of the peak population size by a
reversal to memory of 1 to 2% of the activated cells per day during the death phase.